FDA Raps Supplement Maker Marco Pharma For GMP Violations Surfaced During Inspection

The US Food and Drug Administration directs Marco Pharma International to correct GMP compliance issues identified during a May 2019 site inspection, including quality control and recordkeeping failures, in a warning letter made public 4 February.